Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Macey

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Cancer|February 1, 1994
Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancerJ L Murray, D J Macey, L P Kasi, et al.
The International Journal of Biological Markers|October 1, 1991
Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibodyS J DeNardo, K A Warhoe, L F O'Grady, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1986
Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancerK Koizumi, G L DeNardo, S J DeNardo, et al.
Cancer Research|December 1, 1995
Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatmentJ L Murray, D J Macey, E J Grant, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategyS J DeNardo, L F O'Grady, D J Macey, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trialD J Macey, E J Grant, L Kasi, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Cancer|February 1, 1994
Phase II radioimmunotherapy trial with 131I-CC49 in colorectal cancerJ L Murray, D J Macey, L P Kasi, et al.
The International Journal of Biological Markers|October 1, 1991
Radioimmunotherapy for breast cancer: treatment of a patient with I-131 L6 chimeric monoclonal antibodyS J DeNardo, K A Warhoe, L F O'Grady, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1996
Prediction of radiation doses from therapy using tracer studies with iodine-131-labeled antibodiesD A DeNardo, G L DeNardo, A Yuan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1986
Multicompartmental analysis of the kinetics of radioiodinated monoclonal antibody in patients with cancerK Koizumi, G L DeNardo, S J DeNardo, et al.
Cancer Research|December 1, 1995
Enhanced TAG-72 expression and tumor uptake of radiolabeled monoclonal antibody CC49 in metastatic breast cancer patients following alpha-interferon treatmentJ L Murray, D J Macey, E J Grant, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Quantitative imaging of mouse L-6 monoclonal antibody in breast cancer patients to develop a therapeutic strategyS J DeNardo, L F O'Grady, D J Macey, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Treatment of B cell malignancies with 131I Lym-1 monoclonal antibodiesS J DeNardo, G L DeNardo, L F O'Grady, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 18, 2001
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I studyR F Meredith, R D Alvarez, E E Partridge, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effect of recombinant alpha-interferon on pharmacokinetics, biodistribution, toxicity, and efficacy of 131I-labeled monoclonal antibody CC49 in breast cancer: a phase II trialD J Macey, E J Grant, L Kasi, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 13, 2000
Low-dose, fractionated radioimmunotherapy for B-cell malignancies using 131I-Lym-1 antibodyG L DeNardo, S J DeNardo, K R Lamborn, et al.
Pageof 8